Sona Nanotech Inc. (CSE:SONA)
0.2900
+0.0050 (1.75%)
Mar 31, 2025, 12:36 PM EST
Sona Nanotech Company Description
Sona Nanotech Inc. operates as a nanotechnology life sciences company.
It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests.
Sona Nanotech Inc. is based in Halifax, Canada.
Sona Nanotech Inc.

Country | Canada |
Founded | 2013 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | David Regan |
Contact Details
Address: Purdy’s Wharf Tower II Halifax, B3J 3R7 Canada | |
Phone | 902 442 0653 |
Website | sonanano.com |
Stock Details
Ticker Symbol | SONA |
Exchange | Canadian Securities Exchange |
Fiscal Year | November - October |
Reporting Currency | CAD |
ISIN Number | CA83541C1059 |
SIC Code | 1000 |
Key Executives
Name | Position |
---|---|
David Andrew Regan | Chief Executive Officer |
Dr. Len Pagliaro Ph.D. | CSO and Director |
Dr. Carman Giacomantonio M.D., M.Sc. | Chief Medical Officer |
Dr. Kulbir Singh Ph.D. | Co-Founder and Head of Research & Development |
Dr. Mike McAlduff | Director of Research & Development and Production and Founder |
Dr. Gerrard Marangoni | Co-Founder and Member of Scientific Advisory Board |
Darren Rowles | Head of Diagnostics |